|
|
-
128 (46%) experienced major efficacy
-
81 (29%) experienced moderate efficacy
-
25 (9%) experienced slight efficacy
-
12 (4%) experienced no efficacy
-
|
-
51 (18%) experienced severe side effects
-
86 (31%) experienced moderate side effects
-
90 (32%) experienced mild side effects
-
52 (19%) experienced no side effects
|
279 |
Lamotrigine
(Lamictal ODT Green Titration Kit, Lamictin, Lamictal ODT Orange Titration Kit, Lamictal)
|
-
81 (42%) experienced major efficacy
-
53 (28%) experienced moderate efficacy
-
25 (13%) experienced slight efficacy
-
11 (6%) experienced no efficacy
-
|
-
22 (12%) experienced severe side effects
-
55 (29%) experienced moderate side effects
-
70 (37%) experienced mild side effects
-
44 (23%) experienced no side effects
|
191 |
Topiramate
(Topamax Sprinkle, Topictal, Toprel, Topamax)
|
-
38 (29%) experienced major efficacy
-
47 (36%) experienced moderate efficacy
-
20 (15%) experienced slight efficacy
-
12 (9%) experienced no efficacy
-
|
-
30 (23%) experienced severe side effects
-
49 (37%) experienced moderate side effects
-
26 (20%) experienced mild side effects
-
27 (20%) experienced no side effects
|
132 |
Carbamazepine
(Shire Carbamazepine, Hermolepsin retard, Equetro, Carbatrol ER)
|
-
52 (41%) experienced major efficacy
-
35 (28%) experienced moderate efficacy
-
20 (16%) experienced slight efficacy
-
9 (7%) experienced no efficacy
-
|
-
27 (21%) experienced severe side effects
-
40 (32%) experienced moderate side effects
-
37 (29%) experienced mild side effects
-
22 (17%) experienced no side effects
|
126 |
Phenytoin
(Phenytoin liquid, Dilantin Infatabs, Epamin, Phenytek)
|
-
43 (40%) experienced major efficacy
-
29 (27%) experienced moderate efficacy
-
16 (15%) experienced slight efficacy
-
10 (9%) experienced no efficacy
-
|
-
29 (27%) experienced severe side effects
-
31 (29%) experienced moderate side effects
-
24 (22%) experienced mild side effects
-
23 (21%) experienced no side effects
|
107 |
Divalproex sodium
(Divalproex sodium ER, Novo-Divalproex, Depakote Sprinkles, Depakote ER)
|
-
40 (38%) experienced major efficacy
-
33 (32%) experienced moderate efficacy
-
10 (10%) experienced slight efficacy
-
16 (15%) experienced no efficacy
-
|
-
37 (36%) experienced severe side effects
-
30 (29%) experienced moderate side effects
-
28 (27%) experienced mild side effects
-
9 (9%) experienced no side effects
|
104 |
|
|
-
19 (30%) experienced major efficacy
-
19 (30%) experienced moderate efficacy
-
13 (21%) experienced slight efficacy
-
4 (6%) experienced no efficacy
-
|
-
13 (21%) experienced severe side effects
-
17 (27%) experienced moderate side effects
-
16 (25%) experienced mild side effects
-
17 (27%) experienced no side effects
|
63 |
|
|
-
17 (28%) experienced major efficacy
-
15 (25%) experienced moderate efficacy
-
8 (13%) experienced slight efficacy
-
8 (13%) experienced no efficacy
-
|
-
10 (17%) experienced severe side effects
-
19 (32%) experienced moderate side effects
-
20 (33%) experienced mild side effects
-
11 (18%) experienced no side effects
|
60 |
|
|
-
18 (33%) experienced major efficacy
-
16 (29%) experienced moderate efficacy
-
6 (11%) experienced slight efficacy
-
7 (13%) experienced no efficacy
-
|
-
17 (31%) experienced severe side effects
-
15 (27%) experienced moderate side effects
-
13 (24%) experienced mild side effects
-
10 (18%) experienced no side effects
|
55 |
Clonazepam
(DOM-Clonazepam, Paxam, APO Clonazepam, Clonotril)
|
-
7 (19%) experienced major efficacy
-
11 (30%) experienced moderate efficacy
-
11 (30%) experienced slight efficacy
-
3 (8%) experienced no efficacy
-
|
-
7 (19%) experienced severe side effects
-
8 (22%) experienced moderate side effects
-
13 (35%) experienced mild side effects
-
9 (24%) experienced no side effects
|
37 |
|
|
-
11 (38%) experienced major efficacy
-
9 (31%) experienced moderate efficacy
-
1 (3%) experienced slight efficacy
-
4 (14%) experienced no efficacy
-
|
-
1 (3%) experienced severe side effects
-
5 (17%) experienced moderate side effects
-
18 (62%) experienced mild side effects
-
5 (17%) experienced no side effects
|
29 |
Gabapentin
(DOM-Gabapentin, PMS-Gabatentin, APO-Gabapentin, Gabaran)
|
-
4 (15%) experienced major efficacy
-
12 (44%) experienced moderate efficacy
-
2 (7%) experienced slight efficacy
-
4 (15%) experienced no efficacy
-
|
-
10 (37%) experienced severe side effects
-
4 (15%) experienced moderate side effects
-
11 (41%) experienced mild side effects
-
2 (7%) experienced no side effects
|
27 |
|
|
-
12 (50%) experienced major efficacy
-
4 (17%) experienced moderate efficacy
-
3 (13%) experienced slight efficacy
-
2 (8%) experienced no efficacy
-
|
-
5 (21%) experienced severe side effects
-
9 (38%) experienced moderate side effects
-
5 (21%) experienced mild side effects
-
5 (21%) experienced no side effects
|
24 |
|
|
-
5 (21%) experienced major efficacy
-
12 (50%) experienced moderate efficacy
-
3 (13%) experienced slight efficacy
-
3 (13%) experienced no efficacy
-
|
-
6 (25%) experienced severe side effects
-
10 (42%) experienced moderate side effects
-
4 (17%) experienced mild side effects
-
4 (17%) experienced no side effects
|
24 |
Lorazepam
(Sandoz Lorazepam, Lorenin, Orfidal, Tranquipam)
|
-
18 (82%) experienced major efficacy
-
1 (5%) experienced moderate efficacy
-
2 (9%) experienced slight efficacy
-
0 (0%) experienced no efficacy
-
|
-
3 (14%) experienced severe side effects
-
2 (9%) experienced moderate side effects
-
8 (36%) experienced mild side effects
-
9 (41%) experienced no side effects
|
22 |